Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply

Lancet. 2020 Feb 15;395(10223):492-493. doi: 10.1016/S0140-6736(19)32544-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Cardiotoxicity*
  • Humans
  • Receptor, ErbB-2
  • Trastuzumab

Substances

  • Receptor, ErbB-2
  • Trastuzumab